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Abstract
Background: Information technology (IT) is increasingly being used in general practice to manage
health care including type 2 diabetes. However, there is conflicting evidence about whether IT
improves diabetes outcomes. This review of the literature about IT-based diabetes management
interventions explores whether methodological issues such as sample characteristics, outcome
measures, and mechanisms causing change in the outcome measures could explain some of the
inconsistent findings evident in IT-based diabetes management studies.
Methods: Databases were searched using terms related to IT and diabetes management. Articles
eligible for review evaluated an IT-based diabetes management intervention in general practice and
were published between 1999 and 2009 inclusive in English. Studies that did not include outcome
measures were excluded.
Results: Four hundred and twenty-five articles were identified, sixteen met the inclusion criteria:
eleven GP focussed and five patient focused interventions were evaluated. Nine were RCTs, five
non-randomised control trials, and two single-sample before and after designs. Important sample
characteristics such as diabetes type, familiarity with IT, and baseline diabetes knowledge were not
addressed in any of the studies reviewed. All studies used HbA1c as a primary outcome measure,
and nine reported a significant improvement in mean HbA1c over the study period; only two studies
reported the HbA1c assay method. Five studies measured diabetes medications and two measured
psychological outcomes. Patient lifestyle variables were not included in any of the studies reviewed.
IT was the intervention method considered to effect changes in the outcome measures. Only two
studies mentioned alternative possible causal mechanisms.
Conclusion: Several limitations could affect the outcomes of IT-based diabetes management
interventions to an unknown degree. These limitations make it difficult to attribute changes solely
to such interventions.
Published: 17 November 2009
BMC Family Practice 2009, 10:72 doi:10.1186/1471-2296-10-72
Received: 20 April 2009
Accepted: 17 November 2009
This article is available from: http://www.biomedcentral.com/1471-2296/10/72
© 2009 Costa et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Family Practice 2009, 10:72 http://www.biomedcentral.com/1471-2296/10/72
Page 2 of 8
(page number not for citation purposes)
Background
Recent advances in Information Technology (IT) have
been used to manage chronic diseases including diabetes
mellitus. Specifically, IT can enhance communication
among health professionals (HPs) and patients [1], and
improve diabetes management [2]. A number of IT appli-
cations are currently available including electronic patient
registers, electronic decision support systems, videocon-
ferencing, telemedicine, biometric devices capable of
uploading information such as blood glucose test results
to the Internet or the HP's computer and Internet-based
interactive patient support networks [3].
Type 2 diabetes mellitus is a chronic progressive disease
associated with long term complications and high mor-
bidity and mortality rates [4]. Between 1999 and 2000 the
Australian prevalence of diabetes was 7.4% [5] and is pro-
jected to reach 15% by 2031 [6]. Type 2 diabetes accounts
for 85% to 96% of all diagnosed cases and is reported to
be largely due to lifestyle factors such as calorie dense
diets, obesity and inactivity [5].
Diabetes management includes achieving HbA1c < 7%,
reducing hyperglycaemia symptoms, preventing compli-
cations, appropriate self-care, and enhancing quality of
life [7,8]. In Australia, general practitioners (GPs) receive
financial incentives to use structured GP management
plans (GPMPs) and work collaboratively with nurses and
allied HPs in Team Care Arrangements (TCAs) to manage
a number of chronic diseases including diabetes. Interdis-
ciplinary TCAs can result in diabetes care consistent with
management guidelines and HbA1c close to 7% [9]. How-
ever, diabetes management is often inadequate despite
care plans [10].
Several barriers prevent GPs in Australia from using struc-
tured diabetes care plans (Table 1). Many of these barriers
relate to insufficient time, knowledge and inadequate
communication among HPs. A shift in focus from acute to
chronic care is needed to successfully address these barri-
ers. A structured approach to care planning, which could
be facilitated by IT, could begin to address barriers associ-
ated with time constraints, knowledge deficits and inade-
quate communication among HPs. Significantly, IT care
planning systems need to be easily integrated into general
practice. However, there appears to be little research con-
ducted in Australia that has examined the impact of IT on
diabetes management.
One Australian study explored GP's and HP's use of com-
puter-based GPMP and TCA templates to plan diabetes
care [11]. GPs and HPs had both positive and negative
views about the templates (Table 1). One reason could be
that electronic templates have not addressed many of the
barriers to using care plans shown in Table 1. The authors
concluded that, while GPs used the templates to claim
Medicare items, most did not feel care plans improved the
overall care of patients with chronic diseases [11].
A recent literature review examined 29 IT-based diabetes
management intervention studies using electronic medi-
cal records (EMR) and undefined web-based programs,
within general practice [12]. Several benefits of IT-based
interventions were discussed and a number of barriers
were identified, including some of those shown in Table
1.
The review found the frequency with which diabetes-spe-
cific investigations were performed increased following
Table 1: Barriers to using diabetes interventions in general practice identified in the literature.
Intervention Barrier
Care plans Time constraints
Amount of documentation required to claim *EPC items
Inconsistency between chronic disease care and acute care-oriented systems
Conflicting patient and +GP care goals
Inadequate knowledge about available #AH services
Inadequate training to work within interdisciplinary teams
Difficulty communicating with other °HPs
Long waiting lists
No practice nurses employed within the practice
Electronic templates Time constraints
Unsure of process
Perception that the items were too business-focused
α IT-based diabetes interventions Concerns about confidentiality
Staff shortages
Time constraints
Inadequate training
Anxiety about change
Note. *EPC = Enhanced Primary Care; +GP = general practitioner; #AH = Allied Health; °health professionals; αIT = information technology.BMC Family Practice 2009, 10:72 http://www.biomedcentral.com/1471-2296/10/72
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the introduction of IT-based interventions [12]. However,
improved HbA1c and cholesterol levels were inconsistent
among the studies reviewed. The review did not scrutinise
the study methodologies. It is possible that methodologi-
cal factors could have influenced the results, and need to
be taken into account to determine whether they could
help explain the inconsistent findings. Thus, using IT in
diabetes management does not appear to have overcome
existing IT management barriers in general practice, espe-
cially time constraints and inadequate training.
The aim of the current review of the literature about IT-
based diabetes management interventions was to deter-
mine the extent to which methodological issues could
explain the inconsistent findings among studies that
examined the effect of IT-based management interven-
tions on diabetes outcomes. The review was undertaken to
answer the following question: what are the methodolog-
ical limitations associated with (1) sample characteristics,
(2) outcome measures and (3) mechanisms causing
change in the outcome measures of studies that evaluated
IT-based diabetes management interventions in general
practice? Cost-benefit and cost-effectiveness issues are not
addressed in this paper.
Methods
Search Strategy
Databases searched included the Medical Literature Anal-
ysis and Retrieval System Online (Medline), the Cumula-
tive Index to Nursing and Allied Health Literature
(CINHAL), PubMed, and the American Psychological
Association Online Database (PsychInfo). The reference
lists of extracted articles were hand searched for additional
relevant articles. Search terms using the Medical Subject
Headings (MeSH) thesaurus were: diabetes mellitus, type
2/or diabetes mellitus AND disease management AND
informatics OR computerised medical records systems.
Inclusion Criteria
Original articles that evaluated an IT diabetes manage-
ment intervention in general practice published between
1999 and 2009 inclusive in English were reviewed. These
included randomised control trials (RCTs) and pretest-
post-test designs.
Exclusion Criteria
Articles that evaluated IT diabetes management interven-
tions in hospital settings or other chronic diseases were
excluded. Articles that did not include diabetes-related
metabolic outcomes (HbA1c, lipids, renal function) as a
primary outcome measure, literature review papers, and
opinion articles were also excluded.
Data Analysis
Titles and abstracts were independently reviewed by two
of the authors during January and February 2009. Follow-
ing the initial abstract review, complete articles were
retrieved if they met the inclusion criteria. The Australian
National Health and Medical Research Council
(NHMRC) guidelines for appraising the quality of inter-
vention studies [13] were used to assess the studies
reviewed. Where the eligibility of an article was unclear,
the authors engaged in discussion until consensus was
reached. A systematic review of the relevant studies was
not conducted because the study designs and evaluated
interventions were heterogeneous. Therefore, guidelines
for undertaking systematic reviews such as the PRISMA
statement [14] were not followed.
Results
Descriptive Statistics
A total of 425 articles were identified. Sixteen met the
inclusion criteria [15-30] (Table 2). Two articles were
based on a single intervention as part of the American
Longitudinal Informatics for Diabetes Education and
Telemedicine (IDEATel) Project, and separately examined
psychological [19] and physiological [18] outcomes. The
remaining 14 articles evaluated 14 different IT-based
interventions. Fourteen studies were conducted in the
United States of America, one in the United Kingdom, and
one in Korea. No Australian studies met the inclusion cri-
teria. Eleven studies evaluated GP-targeted interventions
including: diabetes registries [16,17,25,27,29,30], elec-
tronic management systems [15,24,26,28] and EMRs
[21]. Five studies evaluated patient-targeted interventions
including: telemedicine [18,19], web-based electronic
self-management systems [22,23] and electronic software
support programs [20].
Nine studies were RCTs; three involved randomisation by
GP clusters and two by patients. Only one RCT indicated
that blinding procedures were used. Five studies were
non-randomised control trials. Two studies used a single
sample before and after design.
Limitations were reported in all the studies reviewed
(Table 3). Reported limitations included study design,
sample characteristics, unmeasured variables confound-
ing outcome measures, and participant attrition. The fol-
lowing section describes the limitations of the studies
included in the review according to three issues: sample
characteristics, outcome measures, and mechanisms caus-
ing change in the outcome measures.
Sample Characteristics
Nine studies included both type one and type two diabe-
tes patients, two of these evaluated patient-focused inter-BMC Family Practice 2009, 10:72 http://www.biomedcentral.com/1471-2296/10/72
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ventions [22,23]. None of the studies examined the effect
of diabetes type on the outcome measures.
The IT-based interventions had varying degrees of IT com-
plexity. Yet patient and GP baseline levels of familiarity
and confidence in their ability to use computers were not
reported. Diabetes knowledge at baseline was not
reported in any of the studies reviewed, even though a
main component of patient-focused interventions con-
sisted of providing self-management education.
Outcome measures
All of the studies reviewed included HbA1c as a primary
outcome. One study included HbA1c as the only outcome
measure [29]. Nine studies reported a significant reduc-
tion in mean HbA1c at three months [30], six months
[23,28], 12 months [17-19], three years [29] and five years
[21]. Of these, one RCT [22] and one non-randomised
control trial [21] reported significantly lower mean HbA1c
in the intervention groups compared to controls at follow
up (p < 0.05). One study reported that minimal use of dia-
betes registers was associated with an increase in mean
HbA1c from 7.4 at baseline to 7.8 at follow up (p < .05)
Table 2: Summary of the 16 Studies Reviewed
Design Intervention Country Focus Sample Sample size
(n)
Duration Reference
Cluster blind RCT Electronic decision support system USA GP T1D, T2D 639 21 months [15]
Cluster RCT Diabetes register UK GP T2D 3, 608 15 months [16]
Cluster RCT Diabetes register USA GP T2D 7, 101 12 months [17]
Cluster RCT Electronic telemedicine USA Patient T2D 1, 665 12 months [18]
Cluster RCT Electronic telemedicine USA GP T2D 1, 665 12 months [19]
Cluster RCT Electronic self-management system USA Patient T2D 886 12 months [20]
RCT Electronic self-management system USA Patient T1D, T2D 122 6 months [21]
RCT Electronic self-management system USA Patient T1D, T2D 104 12 months [22]
RCT Electronic self-management system USA Patient T1D, T2D 62 6 months [23]
Nonrandomised cluster 
control trial
Electronic management system USA GP T1D, T2D 6, 646 24 months [24]
Nonrandomised control 
trial
Diabetes register USA GP T1D, T2D 898 20 months [25]
Nonrandomised control 
trial
Personal Digital Assistant (PDA) based 
electronic management system
USA GP T2D 173 16 months [26]
Nonrandomised control 
trial
Diabetes register USA GP T1D, T2D 661 2 years [27]
Nonrandomised control 
trial
Electronic decision support system USA GP T1D, T2D 16 6 months [28]
Single sample before and 
after design
Diabetes register USA GP T1D, T2D 62 3 years [29]
Single sample before and 
after design
Diabetes register Korea GP T1D, T2D 185 3 months [30]
Note. RCT = randomised control trial; GP = general practitioner; T1D = type 1 diabetes; T2D = type 2 diabetes.
Table 3: Limitations associated with study outcomes in 16 studies reviewed
Issue Limitation
Design Not randomised [24,27]
No control group [28]
Short duration of the intervention [[15], 1623]
Sample Sample not representative [22,23]
Small sample size [28]
Sampling population restricted to patients who accessed hospital web page [30]
Intervention effect Unable to determine intervention component contributing to the observed change [23,29]
Unmeasured variable contributing to observed change [28]
Possibility of increased attention to management contributing to observed change [19,20]
Mean baseline HbA1c close to 7% [17,20,25]
Concomitant exposure to another intervention [27]
Participant dropout Non-random participant dropout [19]
Complete data not available for all participants [29]BMC Family Practice 2009, 10:72 http://www.biomedcentral.com/1471-2296/10/72
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[27]. Two of the studies reported the HbA1c assay method
[21,22]. A change in the HbA1c assay method during one
study led to significantly lower HbA1c concentrations [21].
Mean baseline HbA1c in eight of the studies reviewed
ranged between 7.0 and 7.3% [15,17-20,23,24,26]. Inter-
ventions introduced when the mean baseline HbA1c was
9.0 - 11.0% were associated with a significant improve-
ment in HbA1c (7.5 - 7.68%).
Cholesterol levels were assessed in all the studies reviewed
except one [29]. Ten studies measured blood pressure [15-
19,22-24,26,28], two studies measured weight [23,28],
and one measured creatinine [16]. Eight assessed GP
adherence to diabetes complication screening guidelines;
five assessed whether diabetes-specific metabolic indica-
tors were documented in patient files [16,17,29,21,25]
and six studies assessed whether annual foot and eye tests
were performed [16,17,20,24,26,27]. GP adherence meas-
ures assessed could not be found in one study [28].
Five studies reported prescribed oral hypoglycaemic
agents (OHAs) and insulin [15,16,22,25,28]. Four of
these measured the change in the proportion of partici-
pants prescribed OHAs and insulin at baseline and follow
up [15,16,25,28]. The number of patients that were pre-
scribed these medicines increased over a 21 month
period.
Two studies reported psychological outcomes; specifically
self-efficacy and depression. One study reported increased
self-efficacy using the Diabetes Self-Efficacy Scale (DSES)
[31] following the introduction of a patient-targeted IT
intervention [19]. A second study reported the prevalence
of depression reduced from 19% to 12% in the interven-
tion group and 16% to 13% in the comparison group in a
12-month evaluation of a patient-directed electronic
assessment and action plan software program [20].
Patient lifestyle factors were not reported in any of the
studies reviewed.
Mechanisms Causing Change in the Outcome Measures
The causal mechanism responsible for changes in the out-
come measures in the studies reviewed was an IT-based
intervention. Three studies acknowledged that increased
attention to diabetes care or some unmeasured factor
could have contributed to the changes observed in out-
come measures [15,25,30].
Discussion
Nine of the studies reviewed identified an association
between the IT intervention used and the outcome meas-
ures [17-19,21-23,28-30]. However, caution should be
exercised in interpreting the findings of studies, which
evaluated IT-based diabetes management interventions
because a number of different confounding factors may
have influenced the outcomes, some of which were con-
sidered in the current paper.
Sample Characteristics
In IT-based diabetes intervention evaluation studies, sam-
ple characteristics such as diabetes type, familiarity with
IT, and baseline diabetes-related knowledge and skills
may be important factors that could influence the results.
None of the studies appeared to address any of these fac-
tors. While RCT randomisation procedures aim to reduce
the effect of known and unknown confounding variables
[32] it may not be possible to eliminate their effect com-
pletely. Furthermore, randomisation was not undertaken
in seven of the studies reviewed [24-30]. A lack of ran-
domisation may have increased the risk of bias when
assigning participants to intervention and control groups.
This may have influenced the outcome measures to an
unknown degree.
Diabetes Type
Type one diabetes is unique in that management always
involves medication, whereas type two diabetes may be
managed using diet and lifestyle. These differences could
influence individuals' self-management strategies and
affect outcome measures.
Familiarity with IT
Cognitive ability affects engagement with technology such
as learning new skills and new ways of performing famil-
iar tasks such as emailing, participating in chat rooms and
navigating the Internet [33]. Advanced disease progres-
sion, multiple co-morbidities, and natural ageing, may
reduce the cognitive capacity of participants to learn the
skills necessary to engage with IT-based interventions.
Thus, cognitive ability could have influenced the outcome
measures of some studies to an unknown degree, but was
not discussed in the studies reviewed.
Type 2 diabetes is common in older adults (> 60 years)
[34]. Compared with younger adults, older adults report
greater anxiety about using computers, lower use of tech-
nology [33] and less confidence in their ability to use
computers [35]. Therefore, some patients may have expe-
rienced anxiety about engaging in computer-related inter-
ventions such as accessing support materials on the
Internet and uploading blood glucose test results to study
websites. However, these potential confounders were not
explored or discussed in any of the studies reviewed.
GPs' initial level of computer literacy and experience with
the technology may influence their acceptance and use of
new informatics-based interventions [36,37]. Some GPs
who trained before the introduction of computers into
general practice may be less confident to use them thanBMC Family Practice 2009, 10:72 http://www.biomedcentral.com/1471-2296/10/72
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other GPs, such as more recently trained GPs. High levels
of computer anxiety may be associated with reluctance to
engage with online interventions to an unknown degree.
Therefore, when evaluating any new IT intervention in
general practice it is important to examine professionals'
perceptions and acceptance of the technology, because
these factors could influence the outcomes of the inter-
vention, yet this was not assessed in any of the studies
reviewed.
Diabetes Knowledge
Not all patients with diabetes will benefit from an IT-
based management intervention [1]. Many individuals,
particularly those diagnosed many years prior to partici-
pating in an intervention study, may have already devel-
oped strategies and acquired the relevant knowledge to
manage their diabetes with minimal professional inter-
vention. In particular, patients who are able to maintain
their HbA1c close to 7% may have well developed self-
management strategies and knowledge. Self-management
education interventions may only be effective for partici-
pants with inadequate diabetes-specific knowledge.
Therefore, it may be of value to assess diabetes knowledge
and skill levels prior to introducing interventions that aim
to up-skill individuals with diabetes. This was not
reported in any of the studies reviewed.
Outcome measures
Diabetes Management Goals
HbA1c was the primary outcome measure used in the stud-
ies reviewed. HbA1c provides an average measure of blood
glucose over the previous 90 to 120 days [8]. It is an objec-
tive measure of glycaemic control and is unaffected by
self-report bias. However, a number of factors can affect
HbA1c and thus influence the outcome. First, frequent
hypoglycaemic episodes, anaemia, haemoglobinopethies
and excessive blood loss can lower HbA1c [7]. These fac-
tors were not assessed in any of the studies reviewed. Like-
wise, they are rarely, if ever, considered when developing
care plans.
Second, HbA1c may be an appropriate outcome measure
only when it is elevated at baseline. Individuals with good
diabetes self-management before participating in an IT-
based intervention may not derive any benefit from par-
ticipation and may confound study results. IT diabetes
management interventions may need to be introduced to
populations where diabetes is poorly controlled in order
to effect changes, as was the case in three of the studies
reported [22,28,29].
Third, there may be interlaboratory variations if HbA1c
was not measured in the same laboratory. Thus, it may be
unwise to make comparisons among studies using differ-
ent laboratories for HbA1c results. As well as process and
structure outcomes, psychological state, medication status
and lifestyle factors need to be assessed.
Diabetes Medications
When lifestyle changes alone do not control blood glu-
cose levels among people with type 2 diabetes, glucose
lowering medications (OHAs or insulin) are introduced
[8]. Medications, doses, and dose intervals are altered over
time as needed to maintain metabolic control. Therefore,
medication status at baseline and changes over time can
provide an indication of disease progression in type 2 dia-
betes. None of the studies reviewed assessed the effect of
OHAs or insulin on outcomes or whether the medicine
regimens changed because of the IT interventions. With-
out such information, it is not possible to tease out the
effects of OHAs or insulin on outcomes or to attribute
change solely to IT-based interventions.
Psychological Factors
Psychological factors were rarely measured in any of the
studies reviewed. However, a range of psychological vari-
ables can influence glycaemic control. High levels of dia-
betes self-efficacy are directly associated with lower HbA1c
[38,39], yet only one study measured changes in self-effi-
cacy following the introduction of an IT-based interven-
tion [19]. One study evaluated a patient-directed IT
intervention that used electronically delivered strategies
to enhance diabetes self-efficacy beliefs and self-manage-
ment behaviours, yet did not report self-efficacy as an out-
come measure [23]. While the authors reported an
improvement in HbA1c following the intervention, it is
not clear whether the change was due to a change in par-
ticipants' self-efficacy, the intervention, or any other fac-
tor. Thus, caution must be exercised when attributing the
findings of this study to the IT intervention.
Depression is common among people with diabetes and
is associated with poor metabolic control, poor treatment
adherence and reduced quality of life [5], and may influ-
ence outcomes of studies evaluating new diabetes man-
agement interventions. Yet depression was only
considered in one of the studies reviewed [20]. Further-
more, there is only limited evidence that IT-based inter-
ventions reduce depression, therefore the variable causing
a change in depression levels in Glasgow et al.'s study
[20], is unclear. Being part of a study or receiving
increased attention and care from HPs may reduce depres-
sion among study participants rather than the interven-
tion.
Lifestyle Factors
Social and lifestyle factors influence how well people
manage their diabetes. Income and education deficits are
associated with inadequate self-care, and affect diabetes
outcomes [5]. Inadequate diabetes-related knowledge andBMC Family Practice 2009, 10:72 http://www.biomedcentral.com/1471-2296/10/72
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skills impair people's ability to successfully undertake self-
management [40]. However, lifestyle factors were not
reported in any of the studies reviewed, and represents a
significant limitation of the current literature.
Mechanisms Causing Change in the Outcome Measures
The first possible mechanism responsible for reported
changes in outcome measures, the mechanism considered
in all of the studies reviewed, was the IT mode of delivery.
That is, delivering diabetes management interventions
electronically is a possible mechanism causing change in
the outcome measures. However, factors other than the
method of delivery could contribute to observed changes
in outcome measures.
Good diabetes management and GP adherence to man-
agement guidelines may partially account for changes in
HbA1c. Most of the studies reviewed compared the IT-
based intervention to standard diabetes management.
Appropriate diabetes management effects a change in out-
come measures, regardless of the mode of delivery. Yet the
appropriateness of people's management regimens was
not discussed. It is unethical to withhold treatment with
proven efficacy in order to provide a control group for IT
interventions. However, the possibility that diabetes man-
agement per se and not the IT method influenced out-
comes should be considered.
Participating in research can influence outcome measures.
Individuals who choose to take part in a research study
may be motivated to perform well to help the researcher
and confirm to themselves their contribution is valuable
[41]. Therefore, participating in an IT-based intervention
study may have influenced self-management behaviours
in both the intervention and comparison groups, and in
turn affected the outcomes, but this possibility was not
acknowledged in any of the studies reviewed.
Limitations
There are several limitations to the current review, which
could affect the conclusions. First, a systematic literature
review was not undertaken because of the heterogeneity of
the interventions and study designs of the literature iden-
tified. Second, while a search strategy was used, the review
may have omitted important studies evaluating other IT-
based diabetes management interventions. Finally, the
review did not identify any studies conducted within Aus-
tralia. The Australian health system is unique to the health
systems of both the United Kingdom and the United
States, where the majority of the studies reviewed were
conducted. The availability of financial incentives for
using structured care planning within Australia may influ-
ence GPs' use of IT-based diabetes management interven-
tions to an unknown degree.
Conclusion
Given the growing diabetes epidemic, effective diabetes
management interventions suited to general practice are
needed. Due to the limitations of the studies reviewed, the
effectiveness of current IT-based interventions is unclear
and difficult to attribute solely to the interventions. Future
research efforts must give thoughtful attention to method-
ological issues to produce valid, reliable and generalisable
findings. In particular, possible confounding factors need
to be acknowledged and controlled, outcome measures
need to be relevant to the populations being studied and
appropriate methods used to address study aims.
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